Since the beginning of 2020, the world has been experiencing an unprecedented public health emergency caused by the coronavirus disease (COVID-19) pandemic, which has led to progressive introduction of social distancing and other control measures by national governments. To investigate the effects of the pandemic on and the implications for drug markets and people who use drugs in the European Neighbourhood Policy (ENP) countries, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) launched a trendspotter study. This briefing provides a snapshot of the state of play with respect to the impact of COVID-19 on drug markets and people who use drugs in south ENP countries (between March and June 2020).
- A sustainable future for cannabis farmers ‘alternative development’ opportunities in the legal cannabis market
- Harm reduction in action
- Drug decriminalisation: Progress or political red herring?
- Supressing coherence: The UNODC Strategy 2021-2025 and the UN system Common Position on drugs
- Taking stock of half a decade of drug policy - An evaluation of UNGASS implementation
- Impacts of covid-19 on women living with HIV who use drugs in Nepal
- Converging epidemics: COVID-19, HIV & inequality
- New psychoactive substance use in the Republic of Estonia
- Assessment of situation and response of drug use and its harms in the MENA